Table 2. Antimicrobial susceptibility profiles of A. baumannii isolates.
| Isolate | MIC, mg/L (antimicrobial susceptibility category) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMI | MRP | CTX | CFP | CAZ | AMK | CIP | TET | P/T | CL | PB | TIG | |
| Ab10-18 | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | 16 (R) | > 256/4 (R) | 1 (S) | 1 (S) | 4 (I) |
| Ab10-19 | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | > 64 (R) | 64 (R) | > 64 (R) | > 64 (R) | > 256/4 (R) | 2 (S) | 1 (S) | 8 (R) |
| Ab11-20 | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | 4 (S) | > 256/4 (R) | 1 (S) | 1 (S) | 4 (I) |
| Ab11-21 | > 64 (R) | > 64 (R) | > 128 (R) | 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | 8 (I) | > 256/4 (R) | 1 (S) | 1 (S) | 4 (I) |
| Ab11-22 | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | > 64 (R) | > 128 (R) | 64 (R) | 4 (S) | > 256/4 (R) | 1 (S) | 1 (S) | 4 (I) |
| Ab11-23 | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | > 64 (R) | > 128 (R) | 64 (R) | 4 (S) | > 256/4 (R) | 1 (S) | 1 (S) | 2 (S) |
| Ab11-24 | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | 16 (R) | > 256/4 (R) | 1 (S) | 1 (S) | 4 (I) |
| Ab11-25 | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | > 64 (R) | > 128 (R) | 64 (R) | 4 (S) | > 256/4 (R) | 1 (S) | 1 (S) | 2 (S) |
| Ab12-26 | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | 64 (R) | > 128 (R) | 64 (R) | 8 (I) | > 256/4 (R) | 2 (S) | 1 (S) | 2 (S) |
| Ab16-27 | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | > 64 (R) | > 128 (R) | > 64 (R) | 4 (S) | > 256/4 (R) | 1 (S) | 1 (S) | 4 (I) |
MIC = minimum inhibitory concentration, IMI = imipenem, MRP = meropenem, CTX = cefotaxime, CFP = cefepime, CAZ = ceftazidime, AMK = amikacin, CIP = ciprofloxacin, TET = tetracycline, P/T = piperacillin-tazobactam, CL = colistin, PB = polymyxin B, TIG = tigecycline, R = resistant, I = intermediate-resistant, S = susceptible, Ab#-# = A. baumannii isolated year-patient number.